167 related articles for article (PubMed ID: 7997725)
1. Molecular determinants of soft tissue sarcoma proliferation.
Pollock RE
Semin Surg Oncol; 1994; 10(5):315-22. PubMed ID: 7997725
[TBL] [Abstract][Full Text] [Related]
2. Preclinical experimental therapeutic approaches in soft tissue sarcoma.
Hunt KK; Feig BW
Semin Surg Oncol; 1999; 17(1):78-82. PubMed ID: 10402641
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of soft tissue and bone tumors. A review.
Slominski A; Wortsman J; Carlson A; Mihm M; Nickoloff B; McClatchey K
Arch Pathol Lab Med; 1999 Dec; 123(12):1246-59. PubMed ID: 10583931
[TBL] [Abstract][Full Text] [Related]
4. Current aspects of the pathology of soft tissue sarcomas.
Fisher C
Semin Radiat Oncol; 1999 Oct; 9(4):315-27. PubMed ID: 10516379
[TBL] [Abstract][Full Text] [Related]
5. Advances in the understanding of human soft tissue sarcomas: molecular biology and therapeutic strategies (Review).
Milas M; Yu D; Pollock RE
Oncol Rep; 1998; 5(5):1275-9. PubMed ID: 9683850
[TBL] [Abstract][Full Text] [Related]
6. Role of Molecular Profiling in Soft Tissue Sarcoma.
Lindsay T; Movva S
J Natl Compr Canc Netw; 2018 May; 16(5):564-571. PubMed ID: 29752329
[TBL] [Abstract][Full Text] [Related]
7. Modern pathological evaluation of soft tissue sarcoma specimens and its potential role in soft tissue sarcoma research.
Zhang P; Brooks JS
Curr Treat Options Oncol; 2004 Dec; 5(6):441-50. PubMed ID: 15509478
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of soft tissue sarcomas.
Cooper CS; Cornes P
Cancer Treat Res; 1997; 91():31-50. PubMed ID: 9286487
[No Abstract] [Full Text] [Related]
9. Molecular biological studies on soft tissue sarcomas.
Cooper CS; Clark J
Cancer Treat Res; 1993; 67():37-55. PubMed ID: 8102874
[No Abstract] [Full Text] [Related]
10. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
Aragon-Ching JB; Maki RG
Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
[TBL] [Abstract][Full Text] [Related]
11. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
Genevay M; Gengler C; Guillou L
Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
[TBL] [Abstract][Full Text] [Related]
12. [Sarcoma related genes in bone soft tissues].
Hatanaka M
Nihon Seikeigeka Gakkai Zasshi; 1993 Jan; 67(1):118-25. PubMed ID: 8454921
[No Abstract] [Full Text] [Related]
13. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments.
Blay JY; Le Cesne A; Demetri GD
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):29-39. PubMed ID: 32349562
[No Abstract] [Full Text] [Related]
14. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
15. Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern.
Haller F; Knopf J; Ackermann A; Bieg M; Kleinheinz K; Schlesner M; Moskalev EA; Will R; Satir AA; Abdelmagid IE; Giedl J; Carbon R; Rompel O; Hartmann A; Wiemann S; Metzler M; Agaimy A
J Pathol; 2016 Apr; 238(5):700-10. PubMed ID: 26863915
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.
Morimoto Y; Ozaki T; Ouchida M; Umehara N; Ohata N; Yoshida A; Shimizu K; Inoue H
Cancer; 2003 Nov; 98(10):2245-50. PubMed ID: 14601095
[TBL] [Abstract][Full Text] [Related]
17. Epithelioid sarcoma or malignant rhabdoid tumor of soft tissue? Epithelioid immunophenotype and rhabdoid karyotype.
Molenaar WM; DeJong B; Dam-Meiring A; Postma A; DeVries J; Hoekstra HJ
Hum Pathol; 1989 Apr; 20(4):347-51. PubMed ID: 2649435
[TBL] [Abstract][Full Text] [Related]
18. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the genomics of soft tissue sarcomas.
Conley AP; Trent J; Zhang W
Curr Opin Oncol; 2008 Jul; 20(4):395-9. PubMed ID: 18525334
[TBL] [Abstract][Full Text] [Related]
20. Molecular alterations in bone and soft-tissue sarcoma.
Bell RS; Wunder J; Andrulis I
Can J Surg; 1999 Aug; 42(4):259-66. PubMed ID: 10459325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
